ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 188 filers reported holding ADMA BIOLOGICS INC in Q3 2023. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,215,238 | -38.2% | 1,736,100 | -36.3% | 5.01% | -46.3% |
Q2 2023 | $10,059,128 | -24.0% | 2,726,051 | -31.8% | 9.34% | -17.2% |
Q1 2023 | $13,240,000 | -14.7% | 4,000,000 | 0.0% | 11.29% | -17.7% |
Q4 2022 | $15,520,000 | +21.2% | 4,000,000 | -24.1% | 13.71% | +8.0% |
Q3 2022 | $12,804,000 | +6.5% | 5,269,155 | -13.2% | 12.70% | +4.1% |
Q2 2022 | $12,026,000 | +12.9% | 6,073,598 | +4.3% | 12.20% | +23.4% |
Q1 2022 | $10,656,000 | +40.0% | 5,822,798 | +7.9% | 9.89% | +67.4% |
Q4 2021 | $7,611,000 | – | 5,397,798 | – | 5.91% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Velan Capital Investment Management LP | 5,269,155 | $12,804,000 | 12.70% |
Stonepine Capital Management, LLC | 5,000,000 | $12,150,000 | 5.46% |
Altium Capital Management LP | 2,883,710 | $7,007,000 | 2.57% |
AWM Investment Company, Inc. | 5,015,000 | $12,186,000 | 1.85% |
Potomac Capital Management, Inc. | 482,000 | $1,171,000 | 1.34% |
Perceptive Advisors | 10,933,387 | $26,568,000 | 0.77% |
EAM Investors, LLC | 1,427,160 | $3,468,000 | 0.75% |
Clearline Capital LP | 2,496,297 | $6,066,000 | 0.72% |
EAM Global Investors LLC | 836,323 | $2,032,000 | 0.54% |
BOOTHBAY FUND MANAGEMENT, LLC | 8,121,153 | $19,734,000 | 0.49% |